This observation, explained by the presence of glucocorticoid repressive elements in the promoter of the GR gene (NR3C1) (22), suggests that in glioblastoma cells, the phenotypic effects of dexamethasone are mediated by activation of its canonical target, GR. This evidence concerns the gene NR3C1 and glioblastoma.